FBRX
Forte Biosciences Inc
NASDAQ: FBRX · HEALTHCARE · BIOTECHNOLOGY
$28.03
+6.23% today
Updated 2026-04-29
Market cap
$537.90M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.71
Dividend yield
—
52W range
$6 – $36
Volume
0.3M
Forte Biosciences Inc (FBRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-122.30%
ROA
-61.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $51000.00 | $-23.06M | 100.00% | -45,007.84% | -45,207.84% |
| 2016 | $49000.00 | $-33.48M | 100.00% | -64,675.51% | -68,322.45% |
| 2017 | $41000.00 | $-38.93M | 100.00% | -91,778.05% | -94,948.78% |
| 2018 | $18.04M | $-48.95M | 100.00% | -254.23% | -271.43% |
| 2019 | $36000.00 | $-4.07M | -30.56% | -11,288.89% | -11,302.78% |
| 2020 | $0.00 | $-46.49M | — | — | — |
| 2021 | $0.00 | $-21.71M | — | — | — |
| 2022 | $0.00 | $-13.86M | — | — | — |
| 2023 | $0.00 | $-31.48M | — | — | — |
| 2024 | $0.00 | $-35.48M | — | — | — |
| 2025 | $0.00 | $-69.38M | — | — | — |